Cargando…
Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker
OBJECTIVE: Investigate the value of including cerebellar degeneration-related protein 2-like (CDR2L) as a marker in commercial diagnostic tests for anti-Yo–associated paraneoplastic cerebellar degeneration (PCD). METHODS: We included sera and CSF samples from 24 patients with suspected PCD (6 of who...
Autores principales: | Herdlevær, Ida, Haugen, Mette, Mazengia, Kibret, Totland, Cecilie, Vedeler, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057066/ https://www.ncbi.nlm.nih.gov/pubmed/33531379 http://dx.doi.org/10.1212/NXI.0000000000000963 |
Ejemplares similares
-
CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration
por: Eichler, Tilo W., et al.
Publicado: (2013) -
Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration
por: Herdlevær, Ida, et al.
Publicado: (2020) -
Expression of the onconeural protein CDR1 in cerebellum and ovarian cancer
por: Totland, Cecilie, et al.
Publicado: (2018) -
Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis
por: Schubert, Manja, et al.
Publicado: (2014) -
CRMP5 Antibodies—Diagnostic Challenges
por: Totland, Cecilie, et al.
Publicado: (2021)